Endometrial cancer secondary prevention: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
No edit summary
 
Line 3: Line 3:
{{CMG}}{{AE}}{{MD}}
{{CMG}}{{AE}}{{MD}}
==Overview==
==Overview==
The risk of recurrence of endometrial cancer is highest within 2 years. Life-time follow-up is needed, especially within the first 2 years following diagnosis and successful treatment. Routine follow-up visists occur at 3-4 months interval during the first 2 years, at 6 months interval during the next 3 years, and yearly thereafter.
There are no established measures for the secondary prevention of endometrial cancer.


==Secondary Prevention==
==Secondary Prevention==
The risk of recurrence of endometrial cancer is highest within 2 years. Life-time follow-up is needed, especially within the first 2 years following diagnosis and successful treatment.<ref> Follow-up after treatment for uterine cancer. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/uterine/treatment/follow-up/?region=ns. URL Accessed on  September, 22 2015</ref>
There are no established measures for the secondary prevention of endometrial cancer.
 
1. Follow-up visits are routinely scheduled as shown below:
:* Every 3–4 months during the first 2 years
:* Every 6 months during the next 3 years
:* Yearly thereafter
2. Follow-up visit includes:
:* Complete [[physical examination]]
:* Pelvic examination
::* Inguinal nodes
::* [[Pap test]] to detect cancer cells in the upper vagina
3. The following test are recommended to check for recurrence:
:* [[Chest x-ray]] may be done yearly
:* [[CT scan]] may be done if the woman has symptoms or something is found during the examination
:* Serum concentration of cancer antigen 125 (CA125) may be checked for abrupt elevations
4. If a recurrence is detected during follow-up, a thorough oncological reassessment is required for adequate management.


==References==
==References==

Latest revision as of 16:52, 29 November 2018

Endometrial cancer Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Endometrial cancer from other Diseases

Epidemiology and Demographics

Risk factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Endometrial cancer secondary prevention On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Endometrial cancer secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Endometrial cancer secondary prevention

CDC on Endometrial cancer secondary prevention

Endometrial cancer secondary prevention in the news

Blogs on Endometrial cancer secondary prevention

Directions to Hospitals Treating Endometrial cancer

Risk calculators and risk factors for Endometrial cancer secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]

Overview

There are no established measures for the secondary prevention of endometrial cancer.

Secondary Prevention

There are no established measures for the secondary prevention of endometrial cancer.

References


Template:WikiDoc Sources